Introduction

Antimicrobial resistance (AMR) has been identified by the World Health Organization (WHO) as one of the most critical global health threats. It results in reduced efficacy of antibiotics, thereby making the treatment of infections significantly more difficult. Pseudomonas aeruginosa represents a major challenge in the context of AMR due to its intrinsic and acquired resistance mechanisms, particularly in the treatment of bloodstream infections and respiratory tract infections.

To support efforts in clinical decision-making and therapeutic development, the establishment of a comprehensive variant database is essential. This website provides access to a structured variant database designed for advanced genomic analysis and AMR research.